CLSI M22 is a comprehensive guideline that provides recommendations for the quality control of microbiological testing in clinical laboratories. The document outlines the essential requirements for ensuring the accuracy and reliability of microbiological test results, which are critical for diagnosing and treating infectious diseases. The guideline covers various aspects of microbiological testing, including:
Quantitative molecular assays require stringent QC to ensure reproducibility and accuracy. CLSI M22 was developed to address gaps in general QC guidelines (e.g., CLSI EP23) for commercial assays. The third edition (M22-A3) replaced M22-A2, emphasizing assay-specific QC plans based on manufacturer’s instructions and laboratory risk assessment. clsi m22 pdf
CLSI M22 is a critical guideline for microbiological testing in clinical settings. By understanding the key components and best practices outlined in the guideline, laboratories can ensure the accuracy and reliability of microbiological test results. This, in turn, impacts patient safety, standardization, and regulatory compliance. Stay up-to-date with the latest CLSI M22 guidelines and best practices to provide high-quality microbiological testing services. CLSI M22 is a comprehensive guideline that provides